Skip to main content
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc logoLink to The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
. 2016 Jul 25;26(1):20–26. doi: 10.1055/s-0036-1584902

Endovascular Management of Flush Common Iliac Artery Occlusive Disease: Challenges and Solutions

Baker Ghoneim 1,, Walied Eldaly 1, Hussein Elwan 1, Ahmed Taha 1
PMCID: PMC5330752  PMID: 28255211

Abstract

The aim of this study was to assess the difficulties met with possible recommendations in management of flush common iliac artery occlusive disease (FCIAOD).

This a prospective study assessing FCIAOD along the period of 24 months. We defined FCIAOD as more than 90% occlusion of diameter of common iliac artery (CIA) with less than 2 mm patent iliac stump from its origin from the abdominal aorta.

Our study included 51 cases. Technical success was achieved in 47 patients (92%); 82.5% of cases were done via two accesses (65% of cases were done using bilateral femoral). Primary stenting was done in all cases. Sixty-eight percent of cases were treated by unilateral stents (81.3% of them were done using self-expandable) and 32% of cases were treated by kissing stents (50% using self-expandable). Prestent dilatation was selectively used in 77% of cases. Follow-up (12 months) revealed primary patency of 82.5% and secondary patency was 98% with no amputation done. Mortality rate was 4%.

Endovascular treatment provides a successful option for the management of FCIAOD with a technical success rate of 92%, the option of selective use of prestent dilatation. FCIAOD does not preclude the use of unilateral stent in CIA, which can be completed to kissing stents if needed.

Keywords: endovascular, common iliac, ostial lesion, flush, kissing stents, dissection, predilatation


Lesions involving the origin of the common iliac artery (CIA) at aortic bifurcation deserve extra consideration. The main concern is that intervention on one side may compromise the origin of other iliac by movement of an eccentric plaque. One option is the kissing stent technique where stents are placed in bilateral iliac arteries.1

This technique (iliac angioplasty) is applicable not only to chronic ischemia but also to acute limb ischemia. Iliac angioplasty has been used not only as a stand-alone procedure but also as a viable option for improving inflow in patients requiring distal bypass procedures.2

Combined use of iliac artery angioplasty and infrainguinal surgical revascularization is an effective and durable way of treating multilevel atherosclerotic disease.3

Objective

The study aims at assessment of technical success rate and the patency rate (short term) of the endovascular option for treatment of these lesions with review of the role of kissing stents and unilateral stent in treatment of these lesions. In addition, it also studies assessment of the techniques used with review of complications and methods of management.

Patients and Methods

This a prospective study of patients presented to us over a period of 3 years. Flush CIA occlusive disease (FCIAOD) is defined as more than 90% occlusion of diameter of CIA with less than 2 mm patent iliac stump from its origin from the abdominal aorta (Fig. 1A–D). All patients with chronic atherosclerotic FCIAOD presented by claudication, rest pain, or tissue loss were included in the study. Patient presented with embolic disease, acute thrombotic ischemia, trauma, autoimmune disorders or arteritis, or connective tissue disorder (system lupus erythromatosis [SLE], Behcet) were excluded from the study.

Fig. 1.

Fig. 1

(A–D) Flush common iliac artery occlusions (arrow).

Patients presented were subjected to meticulous physical examination, routinely done duplex, and selectively done computed tomography angiography (CTA) and/or conventional angiography. Each patient was assessed for epidemiological features, risk factors, clinical presentation, meticulous clinical examination, imaging used, and presence of other occlusive arterial disease evident by examination, duplex, technique, and complications. Follow-up by means of clinical examination and duplex study after 6, 12, 18, and 24 months of follow-up.

Results

This is a prospective study of 51 cases with FCIAOD. Age varied between 40 and 83 years with mean age of 61 years (Table 1). Most of the patients included in the study were male (79%), while female were (21%). Many comorbidities are encountered in the included patients as shown in Table 2. Most of the patients presented by tissue loss 24 cases, while 16 cases with incapacitating claudication and rests pain was in 11 cases.

Table 1. Age distribution.

Age Percentage (%)
 40–50  4.6
 50–65  90.7
 65–83  4.6

Table 2. Associated comorbidity distribution.

Associated comorbidity Percentage (%)
1) Smoking 76.7
2) Diabetes 76.7
3) Hypertension 67.4
4) Hyperlipidemic 41
5) Renal impairment 16
6) Cardiac patient 18
7) COPD 4

Abbreviation: COPD, chronic obstructive pulmonary disease.

Clinical examination revealed that ipsilateral weak femoral pulse in 12 cases, ipsilateral absent femoral pulse in 28 cases, bilateral absent femoral pulse in 11 cases, and presence of scar of previous operation in 1 case.

Preoperative investigations include Duplex that was done in all cases, while CTA was done in 15 cases. Other arterial occlusive diseases are shown in Table 3.

Table 3. Multilevel disease.

Associated occlusion Percentage (%)
Contralateral common iliac artery 16
Ipsilateral external iliac artery 25
Ipsilateral superfacial femoral artery 28
Ipsilateral crural disease 16

The two femoral arteries were used as the main access in 63% of cases (Table 4). The main wires used were hydrophilic Terumo (Terumo Medical Corporation, Belgium) in 51 cases, while V 18 was used only in 11 cases. Prestent dilatation was used in 77% of cases.

Table 4. Access used.

Access used Percentage (%)
iIpsilateral femoral retrograde only(one access) 4
Contralateral femoral only (one access) 9
Transbrachial only 7
Ipsilateral and contralateral femoral (two accesses) 63
Transbrachial and ipsilateral retrograde femoral (two accesses) 16

Technical success was achieved in 47 patients (92%); 82.5% of cases were done via two accesses (65% of cases were done using bilateral femoral).

Primary stenting was done in all cases; 68% of cases were treated by unilateral stents (81.3% of them were done using self-expandable) and 32% of cases were treated by kissing stents (50% using self-expandable).

Follow-up (24 months) revealed primary patency of 82.5% and secondary patency was 98% with no amputation done. Forty-two cases were patent with no residual stenosis (82.5%). Four cases restenosis and one case occluded unilateral stent, three cases were treated by percutaneous transluminal angioplasty (PTA) alone, one case was treated by PTA and stenting using ipsilateral retrograde femoral access, and one case was treated by restent using bilateral access. Two cases of occluded contralateral iliac artery were treated: one treated by surgery, while the other one was treated by insertion of kissing stents. One case developed a stenosed contralateral iliac that was treated by kissing stents.

Overall, secondary patency rate after 24 months was 98%. Mortality rate was 4%. Minor complications included groin hematoma in four cases, dye allergy in two, and balloon-mounted stent prematurely deployed in external iliac artery (EIA) with no adverse effect.

Discussion

The aorta and the iliac arteries have become a primary field for percutaneous intervention. Easy access and relatively large diameter of target vessels and the usually benign outcome of major complications have contributed to the wide acceptance of percutaneous intervention in this area.4

FCIAOD deserves extra considerations. Concern exists about which access should be used, how to tackle the lesion (from above or below), and whether to use unilateral or kissing stents.

The current study is designed to deal with 51 cases of FCIAOD in the recent era as regard with access, technique, tools, stents, results, and complications.

The age distribution in the current study reflects the higher prevalence of aortoiliac occlusive disease in old age with the mean age of 61 years which coincides with most of the literature with the mean age ranged between 59 and 60 years.5 6 7 8

This may be explained by high incidence of aortoiliac atherosclerosis with advance of age especially in the sixth decade of life. Yet, the study by Lawrentschuk et al conducted in Australia showed a slightly higher mean age of 67 years (range: 44–81). This may be due to that this study was conducted only on stenosis plus the different geographical distribution may have attributed to this slight difference.9

In the current study, male patient constituted approximately 80% of all patients which was by far higher than stated in the literature which ranged from 45 to 68%.5 6 8 10 11 12 On the contrary, male constituted 74% of cases in the study conducted by Lawrentschuk et al.9 This may be attributed to the prevalence of predisposing factors (smoking, hyperlipidemia, stress of life, and hypertension) in the male population.

In the current study, the main associated comorbidity was 76% smokers and diabetic, while 67% were hypertensive. Other associated diseases include hyperlipidemic (41%) and cardiac patient (18%). This may be attributed to increasing comorbid conditions with advanced age.

As shown in Table 5, the current study results coinciding with Timaran et al in the incidence of smoking and hypertension, and this may be attributed to increased incidence of atherosclerosis with these risk factors while different Mouanoutoua et al, Balzer et al, and Björses et al in incidence of diabetes, hyperlipidemia, and cardiac compromise. Yet, we have higher incidences of diabetes than that were mentioned in the literature that may be due to increased life stress and obesity.7 8 12

Table 5. Associated comorbidity NA.

Associated comorbidity Current study Timaran et al Björses et al Greiner et al Mouanoutoa et al. Balzer et al
Smoking 33 85 58 56 67 77
Hypertension 29 70 45 32 42 84
Diabetes 33 40 18 16 29 44
Hyperlipidemia 19 NA NA 24 38 78
Cardiac compromise 8 60 26 NA 67 15
Renal insufficiency 7 NA NA NA NA 9

Abbreviation: NA, not available.

In the current study, the main presentation was tissue loss (48%) and claudication (37%). Nearly 4% were rest pain. This is different than all the literature as shown in the table, the patients being mostly claudicants ranging from 58 to 79%. This may be attributed to paradigm shift of indication of vascular intervention in the European community to include the claudicants and not just critical limb ischemia.7 8 12

In the current study, associated EIA disease (25%), superfacial femoral artery (SFA) (28%), and crural disease (16%) were coinciding with Mouanoutoua et al where associated EIA disease was 26%, SFA 8%, and crural 22%.7

In this study, different accesses were used in each individual according to each case and the usage of two accesses was the majority of cases constituting approximately 80% of cases. Bilateral femoral access was used in 64% and brachial and ipsilateral femoral in 16% of cases, while one access was used in 20% of cases, either brachial or ipsilateral femoral access was used. Brachial approaches when contralateral crossover technique fails or is not appropriate due to bilateral disease. Brachial approach allowed a direct line for recanalization and also helped increase the torque that could be applied to the guide wire. FCIAOD has no nipple; therefore, sometimes, it has difficulties in passing the lesion by use of contralateral approach as wire and catheter slipped in aorta as lacking the required support. In the literature, there are controversies about access to FCIAOD which may be different to access to middle part of CIA occlusion as in the literature.13 14

Bechara et al have advocated a new technique that facilitates the antegrade negotiation of FCIAOD. The technique involves placing an occlusive contralateral iliac artery balloon to assist in recanalizing a flush iliac artery occlusion, thus avoiding the expensive re-entry devices.15

In Balzer et al and Treiman et al, the preferred approach in complete occlusion is to pass the lesion by contralateral approach, then all procedures as debulking and stent insertion were done from ipsilateral retrograde femoral.8 16

Although using only retrograde ipsilateral femoral approach was preferred access used by Ballard et al, Sullivan et al, and Brountzos and Kelekis as it is short, straight, and successful in 80% of cases, yet it has several disadvantages that were mentioned by Thava et al, as it usually creates subintimal dissection which will be a problem in re-entry as thickened aortic intima heralds the re-entry and also dissection may reach to renal and lumbar causing serious effect.2 13 17 18

Therefore, we prefer to better use of two accesses even in unilateral disease either contralateral femoral access or brachial access to do angiography and crossing the lesion, while ipsilateral retrograde femoral used to insert the stent as the end near origin of iliac artery will be deployed first allowing proper and precise insertion meanwhile allowing the usage of self-expandable stent with a great accuracy. In addition, advantages of using two accesses are to do angiography from contralateral approach allowing good planning of work and with the presence of bilateral access, it is easier to convert the procedure to kissing stents as required. It is also possible to use flossing technique which is passage the wires from the contralateral side and crossover then crossing the lesion and picking up the wire from ipsilateral femoral sheath (may be facilitated by a snare but possible without). Thus, there will be a secure passage of balloons and stents. Angiography can still be done by passage of a catheter from the contralateral femoral over a body wire (this usually requires a larger sheath). Flossing technique were also used by Cilingiroglu et al by aid of a snare, it facilitated subintimal recanalization of iliac artery occlusion.19

In the current study, prestent dilatation was used in 74.5% of cases. Gaines advised not to predilate since this decreased the risk of distal embolization. Also, there is some evidence that this results in less intimal hyperplasia. On the contrary, Brountzos and Kelekis, Lumsden et al, Criado et al, and Schneider advocated present dilatation.18 20 21 22 23 Present dilatation had several advantages. It facilitates the second femoral ipsilateral puncture and makes a smooth passage of stent without insult the plaque and allow better sizing of the stent and balloon needed. Predilatation of stenosis was advised especially when very tight lesion as it will enlarge the lumen enough to allow subsequent crossing with long sheath. Meanwhile, it assesses the dilatability of lesion because balloon expansion cannot be assessed. There are some very hard calcific stenoses that may not be amenable to balloon angioplasty at all to find this out when the stent is on the balloon will lead troubles. Predilation can be done by same balloon that will be used for stent deployment or slightly smaller (1–2 mm) under size the stent.22 In addition, it allows the proper selection of size and length of the subsequent stent placement.21 Predilating the lesion is usually advisable if the residual lumen is severely restricted, the stent may not expand sufficiently to allow placement of a poststent balloon angioplasty catheter.24

In the current study, routine stenting were used in all cases that were all treated for occlusion. Routine stenting is coinciding with were mentioned in the literature. Poncyljusz et al and Uberoi and Tsetis advocated routine stent placement.21 25 Routine stenting of the flush CIA occlusion should be always practiced as calcification and irregular and dissection that occur when PTA alone done. In addition, stenting is recommended for in total occlusion primary. This is because calcified lesions typically occurring at the aortic bifurcation are not amenable to balloon dilatation alone.17 Other advantages of routine stenting are reduction in distal embolization by trapping atheromatous plaque and clot between the stent and the arterial wall, shorter procedural time and decreased radiation exposure.17 25 In addition, stent implantation at the ostia appears to be theoretically beneficial as the ostia are prone to severe atherosclerotic changes with extensive calcification.26

In a study mentioned by Jindal et al, 2 years primary and secondary patency rates were higher following stenting when compared with PTA (77 and 88% vs. 64 and 80%).26 While in a study mentioned by White et althat advocated PTA with selective stenting as it has the same results of stenting. The reason behind selective stenting is that it is cost effective than primary stenting. Yet, they did not include all iliac ostial lesion and most of the study were dealing with stenosis not complete occlusion.

In current study, self-expandable stents were deployed in 75% of cases, while balloon-mounted stents were deployed in 25% of cases. In Balzer et al, self-expandable stents were used in 43% of cases, balloon expandable in 54%, and covered stents in 3% of their cases (the covered stents were used to seal perforation). The flexible self-expanding nitinol stents were used for crossover techniques and tortuous vessels and long lesions while balloon-expandable stents (with the stronger radial expansion were used in extremely calcified stenosis and especially CIA occlusions.8 In Kudo et al, balloon-expandable stents were used in (85%), and in Sullivan et al, balloon expandable (85.7%) or self-expanding (14.3%). The reason of more used balloon-expanding stents may be attributed to the more stenotic lesions included in their study range from 80 to 90%; therefore, they used ipsilateral femoral and not crossover so balloon mounted were easier. In Mendelsohn et al, balloon-expandable stents were used only as they only treated stenotic lesions near aortic bifurcation; therefore, precise placement was needed and ipsilateral femoral access was easier.27 Haulon et al used self-expanding stents in 58.5% of patients and balloon-expandable devices in 41.5% of patients.28

Apart from availability and familiarity with specific devices, selection of a stent type for iliac artery depends on tortuosity of iliac arteries, the size of introducing sheath, and mainly the lesion's characteristics determine the appropriate stent type. Eccentric and short calcific lesions typically occurring at aortic bifurcation are likely best treated by balloon-expandable stents. On the contrary, whenever the stent should follow a tortuous path, or is to be placed from contralateral side over the aortic bifurcation, self-expandable stents are recommended because of their flexibility. The fear from usage of self-expandable stents is that they may shorten, however, this fear is reduced with the new stent types and designs.17 29

For aortic bifurcation disease self-expanding nitinol stents are preferred as they are flexible and can adapt to the angle between the aorta and the iliac arteries. Balloon-expandable stents are used when accuracy is required to place the stents in such a manner that the proximal end of the stent is flushed with the ostium of the CIA.26

In our opinion, self-expandable stents are preferred in aortic bifurcation lesions with tortuosity in iliac artery as it is more flexible and can be protruded in aorta and can be done from contralateral side. While balloon mounted are preferred if precise placement near origin of CIA ostium that would not protrude in aorta and heavily calcific lesions.

Besides, currently, there is no clinical evidence of any long-term advantage of one type of stent over the others. The choice of the stent is tailored to the lesion to be treated. Balloon-expandable stents have excellent hoop strength and are best for focal lesions or orifice lesions. Self-expanding stents are more flexible and are useful for long lesions or tortuous arteries.

In the current study, unilateral iliac stent were deployed in 65% of cases while bilateral kissing stents were deployed in 35% of cases. Kissing stents were preferred for the lesions that extend to aortic bifurcation and bilateral disease as it is more effectively trapping the lesions that commonly occur at the aortic carina.

Brountzos and Kelekis recommended the use of simultaneous balloon dilatation at the origins of both CIAs is advocated, even in the presence of unilateral lesion, to protect the contralateral CIA from dissection or plaque dislodgement, with subsequent embolization. Because calcified lesions typically occurring at the aortic bifurcation are not amenable to balloon dilatation alone, “kissing stents” or “aortic reconstruction” technique is applied, the aortic bifurcation reconstruction technique is technically very successful.17 Mohamed et al advocated kissing stents and stated that there were no long-term occlusions following kissing stents in a previously nonsymptomatic/nondisease limb.30 Because lesions with irregular contours, calcification, and haziness may be especially prone to contralateral displacement during unilateral dilation, kissing stents were used to treat these complex plaques, even when they were predominantly unilateral.27

However, Smith et al in a recent retrospective review of patients undergoing percutaneous treatment of unilateral CIA occlusive lesions challenged this long established practice. One hundred seventy-five patients with unilateral ostial lesion of CIA were treated with PTA or stenting without contralateral protection: only 2 patients did the contralateral unprotected CIA develop mild stenosis, 17% and 24%, respectively. The authors concluded that protection of contralateral CIA during PTA or stenting in proximal CIA is not mandatory.31

Lawrentschuk et al advocated also unilateral stent. They justified that as no extra balloon nor stents, thus reducing the cost. In addition, potential arterial wall damage and no arterial compromise where the sum of two balloons exceeds the diameter of the adjacent aorta and with no need to perform a further catheterization with reduction of the cost. They concluded that the use of single balloon technique is a safe alternative to the “kissing balloon” technique for PTA of the proximal CIA.9

In the current study, technical success (evident by return of distal pulse and good refilling in completion angiography) was achieved in 92% of cases. This result is near to what were mentioned by Leville et al that was 94% and Scheinert et al that was 90%, but higher than Greiner et al where technical success was achieved in 86% of their cases. This may be due to that they include more lesions transatlantic intersociety consensus (TASC) D 72% of their cases adding more difficulties in crossing the lesion.32

Although this technical success was lower than other studies that ranged from 97 to 100%.5 6 7 25 27 30 This difference may be attributed to difference in technique and types of lesions where technical success is higher in stenosis than occlusion and also the use of adjunctive methods for recanalization as laser and re-entry devices that may increase the technical success.

In the current study, during the period of follow-up of 24 months, the primary patency of cases was 80%, while secondary patency was 97.5%. Restenosis occurs in 10% of cases and one case with occluded stent complicated contralateral iliac artery occurs in 7.5%. Ostia of major arterial branches, such as the aortic bifurcation, are prone to severe atherosclerotic changes of the vessel wall with extensive calcification.5 Thus, angioplasty with stent placement in this area may have an increased risk for restenosis.19

As shown in Table 6, 24 months patency rate of current study is lower than mentioned in the literature. This may be explained that most of the lesions that were dealt with in the current study were complete occlusion (i.e., TASC C and D) which have poorer long-term results in contrast to other studies that were dealing with stenotic lesions with better long-term patency .Also, associated infrainguinal diseases which would adversely affect the outcome as SFA lesion were 28% of cases in current study.

Table 6. Comparison of published data concerning TS and patency rates of iliac artery and superficial femoral artery lesions NA.

Study TS % Patency rate % Complication %
6 mo 12 mo 24 mo 36 mo
Timaran et al 96 NA 90 NA 74 NA
Scheinert et al 90 NA 84 81 78 NA
Balzer et al 96 NA NA NA 86 6, 9
Mohamad et al NA NA 81 58 NA 4
Björses et al NA NA 97 88 83 NA
Haulon et al NA NA NA 90 NA NA
Hallet et al NA 1ry 92
2ry 95
87
94
83
90
78
88
NA
De Roeck et al NA 1ry 97
2ry 97
95
96
88
93
82
91
NA
Griener et al 86 94 91 65 NA NA

Abbreviations: NA, not available; TS, technical success; 1ry, primary; 2ry, secondary.

In 2005, Schnieder concluded that good runoff was a strong predictor of success after iliac PTA (73% at 3 years vs. 30% for poor runoff). However, in a study done by Scheinert et al concluded that concomitant infrainguinal arterial reconstruction does not improve iliac stent patency in patients undergoing iliac artery stenting with poor distal runoff. Therefore, infrainguinal bypass procedures should be reserved for patients who do not demonstrate clinical improvement after pelvic recanalization. Yet, there are several potential limitations to this study. First, it is a retrospective observational study, with the potential bias and confounding effects inherent in all observational studies. Second, they included patients from two busy institutions with ample experience in both endovascular and peripheral reconstruction and the number of patients was small and prevented further stratified analysis.33

In current study, complications in the contralateral CIA occurred in 7.5% of the cases during insertion of unilateral stent.

In contrast to our results on unilateral stent in iliac artery origin, in a study mentioned by Lawrentschuk et al (2003), there were no major complications in contralateral CIA with the use of unilateral angioplasty without protection of other side. This may be contributed to misplacement of stent that may protrude in the aorta and progression of atherosclerotic disease that occur at the bifurcation and these studies were conducted on stenotic lesions and focal aortoiliac occlusive disease, while our study conducted mainly on complete occlusions.9

Our recommendation that when unilateral iliac stent will be inserted, it must not protrude in the aorta and instead it must be just flushed with the origin of CIA as protruding unilateral iliac stent in the aorta adversely affects the patency rate and outcome.

Conclusion

Endovascular treatment provides a successful option for the management of FCIAOD with a technical success rate of 92%. Technical consideration includes the use of two accesses as a rule and the option of selective use of prestent dilatation. FCIAOD does not preclude the use of unilateral stent in CIA, which can be converted to kissing stents when needed.

References

  • 1.Peden E, Bush R L, Lumsden A B. Massachusetts: Blackwell Publishing; 2006. Aortoiliac occlusive disease; pp. 170–184. [Google Scholar]
  • 2.Ballard J L Bergan J J Singh P Yonemoto H Killeen J D Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost J Vasc Surg 199828194–101., discussion 101–103 [DOI] [PubMed] [Google Scholar]
  • 3.Ali A T, Modrall J G, Lopez J. et al. Emerging role of endovascular grafts in complex aortoiliac occlusive disease. J Vasc Surg. 2003;38(3):486–491. doi: 10.1016/s0741-5214(03)00886-3. [DOI] [PubMed] [Google Scholar]
  • 4.Vorwerk D, Guenther R W, Schürmann K, Wendt G, Peters I. Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients. Radiology. 1995;194(3):745–749. doi: 10.1148/radiology.194.3.7862973. [DOI] [PubMed] [Google Scholar]
  • 5.De Roeck A, Hendriks J M, Delrue F. et al. Long-term results of primary stenting for chronic iliac artery occlusions. Acta Chir Belg. 2006;106(2):187–192. doi: 10.1080/00015458.2006.11679868. [DOI] [PubMed] [Google Scholar]
  • 6.Scheinert D Schröder M Balzer J O Steinkamp H Biamino G Stent-supported reconstruction of the aortoiliac bifurcation with the kissing balloon technique Circulation 1999100(19, Suppl):II295–II300. [DOI] [PubMed] [Google Scholar]
  • 7.Mouanoutoua M, Maddikunta R, Allaqaband S. et al. Endovascular intervention of aortoiliac occlusive disease in high-risk patients using the kissing stents technique: long-term results. Catheter Cardiovasc Interv. 2003;60(3):320–326. doi: 10.1002/ccd.10658. [DOI] [PubMed] [Google Scholar]
  • 8.Balzer J O. et al. Management of arterial access site after percutaneous interventions. Euro PCR. 2004:472–483. [Google Scholar]
  • 9.Lawrentschuk N, Stary D, Miller R J. Percutaneous transluminal angioplasty of stenosis at the common iliac artery origin using a single balloon technique. EJVES Short Reports. 2003;5(4):55–56. [Google Scholar]
  • 10.Leville C D, Kashyap V S, Clair D G. et al. Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg. 2006;43(1):32–39. doi: 10.1016/j.jvs.2005.09.034. [DOI] [PubMed] [Google Scholar]
  • 11.Timaran C H, Stevens S L, Freeman M B, Goldman M H. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg. 2001;34(3):440–446. doi: 10.1067/mva.2001.117148. [DOI] [PubMed] [Google Scholar]
  • 12.Björses K, Ivancev K, Riva L, Manjer J, Uher P, Resch T. Kissing stents in the aortic bifurcation—a valid reconstruction for aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg. 2008;36(4):424–431. doi: 10.1016/j.ejvs.2008.06.027. [DOI] [PubMed] [Google Scholar]
  • 13.Thava V R, Steadb R E, Smithb R P. Subintimal recanalisation and stenting of a common iliac artery occlusion by a left axillary and an ipsilateral femoral retrograde approach using modified gooseneck grab aided by balloon dilatation of “dissection port”. Clin Radiol. 2004;59(6):527–530. doi: 10.1016/j.crad.2004.01.005. [DOI] [PubMed] [Google Scholar]
  • 14.Papavassiliou V G, Walker S R, Bolia A, Fishwick G, London N. Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg. 2003;25(2):125–130. doi: 10.1053/ejvs.2002.1822. [DOI] [PubMed] [Google Scholar]
  • 15.Bechara C F, Barshes N R, Lin P H, Kougias P. Recanalization of flush iliac occlusions with the assistance of a contralateral iliac occlusive balloon. J Vasc Surg. 2012;55(3):872–874. doi: 10.1016/j.jvs.2011.10.029. [DOI] [PubMed] [Google Scholar]
  • 16.Treiman G S Schneider P A Lawrence P F Pevec W C Bush R L Ichikawa L Does stent placement improve the results of ineffective or complicated iliac artery angioplasty? J Vasc Surg 1998281104–112., discussion 113–114 [DOI] [PubMed] [Google Scholar]
  • 17.Sullivan T M Childs M B Bacharach J M Gray B H Piedmonte M R Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients J Vasc Surg 1997255829–838., discussion 838–839 [DOI] [PubMed] [Google Scholar]
  • 18.Brountzos E N, Kelekis D A. Iliac artery angioplasty : technique and results. Acta Chir Belg. 2004;104(5):532–539. doi: 10.1080/00015458.2004.11679610. [DOI] [PubMed] [Google Scholar]
  • 19.Cilingiroglu B. et al. Subintimal snare-assisted dissection for iliac recanalization: a potentially useful tool. Vasc Dis Management. 2007;4(2):41–44. [Google Scholar]
  • 20.Gaines P A. New York: Informa Healthcare USA, Inc; 2008. Iliac occlusive disease (indication for treatment, technical aspects, current results, and troubleshhoting complications) pp. 9–19. [Google Scholar]
  • 21.Poncyljusz W, Falkowski A, Garncarek J, Karasek M, England S, Zawierucha D. Primary stenting in the treatment of focal atherosclerotic abdominal aortic stenoses. Clin Radiol. 2006;61(8):691–695. doi: 10.1016/j.crad.2006.04.004. [DOI] [PubMed] [Google Scholar]
  • 22.Lumsden A B, Lin P H, Bush R L, Chen C. London: Blackwell Publishing; 2006. Endovascular Therapy: Principles of Peripheral Interventions. [Google Scholar]
  • 23.Schnieder P A. Philadelphia: Elsevier Saunders; 2005. Endovascular surgery management of chronic lower extremity ischaemia; pp. 1192–1223. [Google Scholar]
  • 24.Schnieder P A. New York: Informa Healthcare; 2008. The infrarenal aorta, aortic bifurcation, and iliac arteries:advice about balloon angioplasty and stent placement. Endovascular Skills: Guidewire and Catheter Skills for Endovascular Surgery. 3rd ed. [Google Scholar]
  • 25.Uberoi R, Tsetis D. Standards for the endovascular management of aortic occlusive disease. Cardiovasc Intervent Radiol. 2007;30(5):814–819. doi: 10.1007/s00270-007-9123-5. [DOI] [PubMed] [Google Scholar]
  • 26.Haulon S, Mounier-Véhier C, Gaxotte V. et al. Percutaneous reconstruction of the aortoiliac bifurcation with the “kissing stents” technique: long-term follow-up in 106 patients. J Endovasc Ther. 2002;9(3):363–368. doi: 10.1177/152660280200900317. [DOI] [PubMed] [Google Scholar]
  • 27.Kudo T, Chandra F A, Ahn S S. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg. 2005;42(3):466–475. doi: 10.1016/j.jvs.2005.05.002. [DOI] [PubMed] [Google Scholar]
  • 28.Mendelsohn F O Santos R M Crowley J J et al. Kissing stents in the aortic bifurcation Am Heart J 1998136(4 Pt 1):600–605. [DOI] [PubMed] [Google Scholar]
  • 29.Kaufman J A. St. Louis: Mosby; 2004. Vascular intervention; pp. 83–118. [Google Scholar]
  • 30.Sproat I A. St. Louis: SCVIR; 2001. Percutaneous transluminal balloon angioplasty of the aorta and iliac arteries; pp. 179–204. [Google Scholar]
  • 31.Mohamed F, Sarkar B, Timmons G, Mudawi A, Ashour H, Uberoi R. Outcome of “kissing stents” for aortoiliac atherosclerotic disease, including the effect on the non-diseased contralateral iliac limb. Cardiovasc Intervent Radiol. 2002;25(6):472–475. doi: 10.1007/s00270-001-0120-9. [DOI] [PubMed] [Google Scholar]
  • 32.Smith J C, Watkins G E, Taylor F C, Carlson L A, Karst J G, Smith D C. Angioplasty or stent placement in the proximal common iliac artery: is protection of the contralateral side necessary? J Vasc Interv Radiol. 2001;12(12):1395–1398. doi: 10.1016/s1051-0443(07)61696-0. [DOI] [PubMed] [Google Scholar]
  • 33.Greiner A, Dessl A, Klein-Weigel P. et al. Kissing stents for treatment of complex aortoiliac disease. Eur J Vasc Endovasc Surg. 2003;26(2):161–165. doi: 10.1053/ejvs.2002.1882. [DOI] [PubMed] [Google Scholar]

Articles from The International Journal of Angiology : Official Publication of the International College of Angiology, Inc are provided here courtesy of Thieme Medical Publishers

RESOURCES